Lung Cancer vaccine CimaVax-EGF – CIM Cuba

At the recent World Vaccine Congress Washington in April 2012 we had the pleasure of welcoming Dr Diego Venegas Ojeda, as one of our speakers. Dr Venegas is an Oncologist and Assistant Professor of Faculty of Medicine “Alberto Hurtado” at the Universidad Peruana Cayetano Heredia, Committee Immunology Cancer of Latin American Immunology Association. Dr Venegas worked very closely with the …

Looking to the Future: Innovative Approaches to #HIV #Vaccine Development and Immunotherapies

We had the pleasure of welcoming Dr Charles Nicolette, the Chief Scientific Officer and R&D Vice President at Argos Therapeutics at the most recent World Vaccine Congress Washington in April to hear about his work on personalised HIV treatment to patient's own virus strain. Dr Nicolette shared his findings on personalizing RNA-loaded dendritic cell immunotherapies for cancer, HIV and other …

Barry Marshall – Rationale for #Vaccine Delivery: Choosing the right strain from human studies

The Nobel Prize Winner Dr Barry Marshall joined us at the World Vaccine Congress in Washington DC in April this year to share his views on his mission to use the HPPT delivery platform for vaccines, biologics and immunotherapeutics.   In 2005 Barry J. Marshall and J. Robin Warren were awarded the Nobel Prize for Physiology or Medicine in recognition …

Therapeutic vaccines– An introduction of Digital Personal Medicine (DPM) with DermaVir

Dr Julianna Lisziewicz, the President, CEO and Vice President of Research, GeneticImmunity joined us at the 12th annual World Vaccine Congress Washington in April 2012 to talk about GeneticImmunity's very interesting take on personalizing vaccines.   Dr Lisziewicz talked us through her views on why we need to personalize DermaVir and other therapeutic vaccines and presented the DPM concept and …

#wvcusa Promising Needle-free technologies for alternative vaccine delivery by Dr Bruce Weniger

  Dr Bruce Weniger, CAPT, US Public Health Service (ret.), International Professor, Research Institute for Health Sciences, Chiang Mai University delivered a presentation last week at the World Vaccine Congress showing his latest research on promising needle-free technologies for alternative vaccine delivery. There have been numerous advances in needle-free vaccine delivery systems. Dr. Weniger summarized a number of specific examples …

#wvcusa Utilizing Helicobacter pylori platform technology for #vaccine delivery

Dr Barry Marshall, Nobel Prize Winner, Scientific Director at Ondek has delivered a presentation showing his latest research on Helicobacter pylori platform technology (HPPT) and its unique potential as an oral delivery system at the World Vaccine Congress last week. Dr. Marshall described the prospects for a vaccine system using modified Helicobacter pylori which is ingested by drinking and colonizes …

#Vacc-4x nasal #vaccine can effectively treat #HIV

Thirty years after AIDS was first described, there is still no effective vaccine against the HIV virus. Worldwide, roughly 33 million people are HIV-positive. Researchers are working to find out whether a HIV vaccine developed by a Norwegian biotech company can be administered nasally.   In autumn 2011 the Norwegian biotechnology company Bionor Pharma reported promising findings from one of …

GLOBAL SURVEY REPORT OUTLINES 2012 FOCUS

In June 2011, World Vaccine Congress Washington 2012 polled 500 senior vaccine executives to gain their exclusive take on the world of vaccines in 2012 as they see it. Those viewpoints have been collated into a 35 page PDF document for you to download and review. The views made in this document have been used to structure and develop the …